Rhein restored nephrin/podocin and suppressed desmin, thereby protecting podocytes, which are critical for preventing progression to end-stage renal disease (ESRD), in ~30% of ORG patients (6-8, 26). The gene discussed is DES; the disease is chronic kidney disease.